The role of toll-like receptor 2 in inflammation and fibrosis during progressive renal injury

PLoS ONE

Volumn 4, Issue 5, 2009, Pages

  Leemans, Jaklien C ^a   Butter, Loes M ^a   Pulskens, Wilco P C ^a   Teske, Gwendoline J D ^a   Claessen, Nike ^a   van der Poll, Tom ^a   Florquin, Sandrine ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIGLYCAN; CHEMOKINE; COLLAGEN; GLYCOPROTEIN GP 96; HIGH MOBILITY GROUP B1 PROTEIN; LIGAND; METALLOPROTEINASE; TOLL LIKE RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA; MATRIX METALLOPROTEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CASE REPORT; CELL PROLIFERATION; CHRONIC DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GRANULOCYTE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY TUBULE CELL; KIDNEY TUBULE DAMAGE; MACROPHAGE; MALE; MOUSE; MYOFIBROBLAST; NEPHRITIS; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; UPREGULATION; ANIMAL; C57BL MOUSE; DISEASE COURSE; ENZYME ACTIVATION; ENZYMOLOGY; EXTRACELLULAR MATRIX; FIBROBLAST; FIBROSIS; IMMUNOLOGY; INFLAMMATION; KIDNEY; KIDNEY DISEASE; KIDNEY TUBULE; METABOLISM; PATHOLOGY; URETER OBSTRUCTION;

ANIMALIA; MURINAE; MUS;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CHEMOKINES; DISEASE PROGRESSION; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; FIBROBLASTS; FIBROSIS; HUMANS; INFLAMMATION; KIDNEY; KIDNEY DISEASES; KIDNEY TUBULES; LIGANDS; MALE; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED C57BL; TOLL-LIKE RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION; URETERAL OBSTRUCTION;

EID: 66349090273     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005704     Document Type: Article

References (54)

1. Wynn TA (2007) Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 117: 524-529.
2. Becker GJ, Hewitson TD (2000) The role of tubulointerstitial injury in chronic renal failure. Curr Opin Nephrol Hypertens 9: 133-138.
3. Klahr S, Morrissey J (2002) Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 283: F861-875.
4. Strutz F, Neilson EG (2003) New insights into mechanisms of fibrosis in immune renal injury. Springer Semin Immunopathol 24: 459-476.
5. Iwano M, Neilson EG (2004) Mechanisms of tubulointerstitial fibrosis. Curr Opin Nephrol Hypertens 13: 279-284.
6. Leemans JC, Stokman G, Claessen N, Rouschop KM, Teske GJ, et al. (2005) Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 115: 2894-2903.
7. Wu H, Chen G, Wyburn KR, Yin J, Bertolino P, et al. (2007) TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 117: 2847-2859.
8. Pulskens W, Teske G, Butter L, Roelofs JJ, van der Poll T, et al. (2008) Toll-like Receptor-4 Coordinates the Innate Immune Response of the Kidney to Renal Ischemia/Reperfusion Injury. PLoS One 3: e3596.
9. Otte JM, Rosenberg IM, Podolsky DK (2003) Intestinal myofibroblasts in innate immune responses of the intestine. Gastroenterology 124: 1866-1878.
10. Seibl R, Birchler T, Loeliger S, Hossle JP, Gay RE, et al. (2003) Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium. Am J Pathol 162: 1221-1227.
11. Tsuboi N, Yoshikai Y, Matsuo S, Kikuchi T, Iwami K, et al. (2002) Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol 169: 2026-2033.
12. Wolfs TG, Buurman WA, van Schadewijk A, de Vries B, Daemen MA, et al. (2002) In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated up-regulation during inflammation. J Immunol 168: 1286-1293.
13. Johnson GB, Brunn GJ, Kodaira Y, Platt JL (2002) Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol 168: 5233-5239.
14. Johnson GB, Brunn GJ, Platt JL (2003) Activation of mammalian Toll-like receptors by endogenous agonists. Crit Rev Immunol 23: 15-44.
15. Taylor KR, Trowbridge JM, Rudisill JA, Termeer CC, Simon JC, et al. (2004) Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 279: 17079-17084.
16. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, et al. (2004) Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 279: 7370-7377.
17. Jiang D, Liang J, Fan J, Yu S, Chen S, et al. (2005) Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 11: 1173-1179.
18. Saemann MD, Weichhart T, Zeyda M, Staffler G, Schunn M, et al. (2005) Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism. J Clin Invest 115: 468-475.
19. Schaefer L, Babelova A, Kiss E, Hausser HJ, Baliova M, et al. (2005) The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest 115: 2223-2233.
20. Scheibner KA, Lutz MA, Boodoo S, Fenton MJ, Powell JD, et al. (2006) Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol 177: 1272-1281.
21. Warger T, Hilf N, Rechtsteiner G, Haselmayer P, Carrick DM, et al. (2006) Interaction of TLR2 and TLR4 ligands with the N-terminal domain of Gp96 amplifies innate and adaptive immune responses. J Biol Chem 281: 22545-22553.
22. Miyake K (2007) Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors. Semin Immunol 19: 3-10.
23. Johnson GB, Brunn GJ, Tang AH, Platt JL (2003) Evolutionary clues to the functions of the Toll-like family as surveillance receptors. Trends Immunol 24: 19-24.
24. Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, et al. (2007) TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 13: 1324-1332.
25. Kirschning CJ, Schumann RR (2002) TLR2: cellular sensor for microbial and endogenous molecular patterns. Curr Top Microbiol Immunol 270: 121-144.
26. Vabulas RM, Braedel S, Hilf N, Singh-Jasuja H, Herter S, et al. (2002) The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway. J Biol Chem 277: 20847-20853.
27. Vabulas RM, Ahmad-Nejad P, da Costa C, Miethke T, Kirschning CJ, et al. (2001) Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem 276: 31332-31339.
28. Asea A, Rehli M, Kabingu E, Boch JA, Bare O, et al. (2002) Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 277: 15028-15034.
29. Eddy AA (2000) Molecular basis of renal fibrosis. Pediatr Nephrol 15: 290-301.
30. Kuroda M, Sasamura H, Kobayashi E, Shimizu-Hirota R, Nakazato Y, et al. (2004) Glomerular expression of biglycan and decorin and urinary levels of decorin in primary glomerular disease. Clin Nephrol 61: 7-16.
31. Lang A, Benke D, Eitner F, Engel D, Ehrlich S, et al. (2005) Heat shock protein 60 is released in immune-mediated glomerulonephritis and aggravates disease: in vivo evidence for an immunologic danger signal. J Am Soc Nephrol 16: 383-391.
32. Mueller T, Bidmon B, Pichler P, Arbeiter K, Ruffingshofer D, et al. (2003) Urinary heat shock protein-72 excretion in clinical and experimental renal ischemia. Pediatr Nephrol 18: 97-99.
33. Valles P, Jorro F, Carrizo L, Manucha W, Oliva J, et al. (2003) Heat shock proteins HSP27 and HSP70 in unilateral obstructed kidneys. Pediatr Nephrol 18: 527-535.
34. See WA, Zhang G, Chen F, Cao Y, Langenstroer P, et al. (2008) Bacille-Calmette Guerin induces caspase-independent cell death in urothelial carcinoma cells together with release of the necrosis-associated chemokine high molecular group box protein 1. BJU Int.
35. Triantafilou M, Gamper FG, Haston RM, Mouratis MA, Morath S, et al. (2006) Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J Biol Chem 281: 31002-31011.
36. Strutz F, Zeisberg M (2006) Renal fibroblasts and myofibroblasts in chronic kidney disease. J Am Soc Nephrol 17: 2992-2998.
37. Gebbia JA, Coleman JL, JL B (2004) Selective induction of matrix metalloproteinases by Borrelia burgdorferi via toll-like receptor 2 in monocytes. J Infect Dis 189: 113-119.
38. Elass E, Aubry L, Masson M, Denys A, Guérardel Y, et al. (2005) Mycobacterial Lipomannan Induces Matrix Metalloproteinase-9 Expression in Human Macrophagic Cells through a Toll-Like Receptor 1 (TLR1)/TLR2- and CD14-Dependent Mechanism. Infect Immun 73: 7064-7068.
39. McCoy CE, O'Neill LA (2008) The role of toll-like receptors in macrophages. Front Biosci 13: 62-70.
40. Duymelinck C, Dauwe S, De Greef K, Ysebaert D, Verpooten G, et al. (2000) TIMP-1 gene expression and PAI-1 antigen after unilateral ureteral obstruction in the adult male rat. Kidney Int 58: 1186-1201.
41. Pierer M, Rethage J, Seibl R, Lauener R, Brentano F, et al. (2004) Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands. J Immunol 172: 1256-1265.
42. Zhang X, Mosser DM (2008) Macrophage activation by endogenous danger signals. J Pathol 214: 161-178.
43. Hasan UA, Trinchieri G, Vlach J (2005) Toll-like receptor signaling stimulates cell cycle entry and progression in fibroblasts. J Biol Chem 280: 20620-20627.
44. El-Achkar TM, Dagher PC (2006) Renal Toll-like receptors: recent advances and implications for disease. Nat Clin Pract Nephrol 2: 568-581.
45. Anders HJ, Schlondorff D (2007) Toll-like receptors: emerging concepts in kidney disease. Curr Opin Nephrol Hypertens 16: 177-183.
46. Docherty NG, O'Sullivan OE, Healy DA, Fitzpatrick JM, Watson RW (2006) Evidence that inhibition of tubular cell apoptosis protects against renal damage and development of fibrosis following ureteric obstruction. Am J Physiol Renal Physiol 290: F4-13.
47. Aliprantis AO, Yang RB, Mark MR, Suggett S, Devaux B, et al. (1999) Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285: 736-739.
48. Aliprantis AO, Yang RB, Weiss DS, Godowski P, Zychlinsky A (2000) The apoptotic signaling pathway activated by Toll-like receptor-2. Embo J 19: 3325-3336.
49. Li M, Carpio DF, Zheng Y, Bruzzo P, Singh V, et al. (2001) An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J Immunol 166: 7128-7135.
50. Haas M (1997) Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis 29: 829-842.
51. Florquin S, Nunziata R, Claessen N, van den Berg FM, Pals ST, et al. (2002) CD44 expression in IgA nephropathy. Am J Kidney Dis 39: 407-414.
52. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, et al. (1999) Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11: 443-451.
53. Rouschop K, Sewnath M, Claessen N, Roelofs J, Hoedemaeker I, et al. (2004) CD44 deficiency increases tubular damage but reduces renal fibrosis in obstructive nephropathy. J Am Soc Nephrol 15: 674-686.
54. Stokman G, Leemans JC, Stroo I, Hoedemaeker I, Claessen N, et al. (2008) Enhanced mobilization of bone marrow cells does not ameliorate renal fibrosis. Nephrol Dial Transplant 23: 483-491.